{
  "document_id": "BIOAMBERINC_04_10_2013-EX-10.34-DEVELOPMENT AGREEMENT - First Amendment",
  "file_path": "data/CUAD_v1/full_contract_pdf/Part_II/Development/BIOAMBERINC_04_10_2013-EX-10.34-DEVELOPMENT AGREEMENT - First Amendment.pdf",
  "text_length": 6450,
  "chunk_count": 9,
  "vector_store_path": "output/vector_stores/BIOAMBERINC_04_10_2013-EX-10.34-DEVELOPMENT AGREEMENT - First Amendment",
  "summary": "* Confidential treatment requested 1. Section 2.2 of the Development Agreement is hereby amended to allow Cargill at its sole discretion to apply [***] during the period of July 5, \n2011, through  September 30, 2011, to perform the Work Plan in addition to the [***] specified in the unamended Section 2.2. The terms for \ncompensation and expenses for these additional FTEs will be as provided for the original FTEs in Section 2.2.  \n2. Other than as expressly modified by this First Amendment, all terms and conditions of the Development Agreement continue without \nmodification. \nCARGILL, INCORPORATED  \nBio Technology Development Center  \u00a0 \u00a0BIOAMBER S.A.S.\n/s/ Jack Staboch \u00a0 \u00a0\u00a0/s/ Jim Millis\nSignature \u00a0 \u00a0Signature\nVP BioTDC \u00a0 \u00a0CTO\nTitle \u00a0 \u00a0Title\n7/14/11 \u00a0 \u00a07/18/11\n\nAMENDMENT 1 TO DEVELOPMENT AGREEMENT  \nThis is the First Amendment ( \u201cFirst Amendment \u201d) to the Development Agreement ( \u201cDevelopment Agreement \u201d) entered into on April 15,  2010, by \nand between Cargill, Incorporated through its Bio Technology Development Center, having its principal place of business at 15407 McGinty Road \nWest, Wayzata, Minnesota 55391 USA ( \u201cCargill\u201d) and BioAmber S.A.S., having a place of  business at Route de Bazancourt, F -51110, Pomacle \nFrance (\u201cBioAmber \u201d). This First Amendment will be effective as of July 5, 2011, upon the signature of both Cargill and BioAmber.  \nCargill and Bioamber mutually agree as follows:  \n\u00a0 \n\u00a0 \nThe Parties, through their authorized representatives, hereby agree to the terms and conditions of this First Amendment.  \n\u00a0 \n\u00a0 \nCargill  Confidential  \n* Confidential treatment requested 1. Section 2.2 of the Development Agreement is hereby amended to allow Cargill at its sole discretion to apply [***] during the period of July 5,\n\nAMENDMENTS TO COMMERCIAL LICENSE AGREEMENT AND DEVELOPMENT  \nAGREEMENT  \nWHEREAS, Cargill, Incorporated ( \u201cCargill\u201d) and BioAmber S.A.S. ( \u201cBioamber \u201d) entered into a Development Agreement having an Effective \nDate of April 15 , 2010, as amended on July 5 , 2011 (the \u201cDevelopment Agreement \u201d);  \nWHEREAS, Cargill and Bioamber entered into a Commercial License Agreement having an Effective Date of April 15, 2010 (the  \u201cCommercial \nLicense\u201d);  \nWHEREAS, Bioamber now desires to amend the Development Agreement to allow Bioamber to fund a  research project being conducted by \nthe Biotechnology Research Institute ( \u201cBRI\u201d), which involves the molecular re -engineering of a Methylotroph owned by BRI and the development \nof a lab scale fermentation design for using the re -engineered  Methylotroph to make succinic acid or salts thereof from a methanol feedstock (the \n\u201cBRI Project \u201d). The BRI Project will be co -funded by funds available from the Canadian National Research Council;\n\n* Confidential  treatment requested CARGILL, INCORPORATED\nBy:\u00a0\u00a0 /s/ Pirkko Suominen\n\u00a0Name: Pirkko Suominen\nTitle: Director, Bio Technology Development \nCenter, Minneapol is\nDate:\u00a0 10/19/2011\nBIOAMBER, SAS\nBy:\u00a0\u00a0 /s/ Jean -Fran\u00e7ois\u00a0Huc\n\u00a0Name: Jean -Fran\u00e7ois\u00a0Huc\nTitle: President\nDate:\u00a0 October 15, 2011",
  "parties": "AMENDMENT 1 TO DEVELOPMENT AGREEMENT  \nThis is the First Amendment ( \u201cFirst Amendment \u201d) to the Development Agreement ( \u201cDevelopment Agreement \u201d) entered into on April 15,  2010, by \nand between Cargill, Incorporated through its Bio Technology Development Center, having its principal place of business at 15407 McGinty Road \nWest, Wayzata, Minnesota 55391 USA ( \u201cCargill\u201d) and BioAmber S.A.S., having a place of  business at Route de Bazancourt, F -51110, Pomacle \nFrance (\u201cBioAmber \u201d). This First Amendment will be effective as of July 5, 2011, upon the signature of both Cargill and BioAmber.  \nCargill and Bioamber mutually agree as follows:  \n\u00a0 \n\u00a0 \nThe Parties, through their authorized representatives, hereby agree to the terms and conditions of this First Amendment.  \n\u00a0 \n\u00a0 \nCargill  Confidential  \n* Confidential treatment requested 1. Section 2.2 of the Development Agreement is hereby amended to allow Cargill at its sole discretion to apply [***] during the period of July 5,\n\n* Confidential treatment requested 1. Section 2.2 of the Development Agreement is hereby amended to allow Cargill at its sole discretion to apply [***] during the period of July 5, \n2011, through  September 30, 2011, to perform the Work Plan in addition to the [***] specified in the unamended Section 2.2. The terms for \ncompensation and expenses for these additional FTEs will be as provided for the original FTEs in Section 2.2.  \n2. Other than as expressly modified by this First Amendment, all terms and conditions of the Development Agreement continue without \nmodification. \nCARGILL, INCORPORATED  \nBio Technology Development Center  \u00a0 \u00a0BIOAMBER S.A.S.\n/s/ Jack Staboch \u00a0 \u00a0\u00a0/s/ Jim Millis\nSignature \u00a0 \u00a0Signature\nVP BioTDC \u00a0 \u00a0CTO\nTitle \u00a0 \u00a0Title\n7/14/11 \u00a0 \u00a07/18/11\n\nAMENDMENTS TO COMMERCIAL LICENSE AGREEMENT AND DEVELOPMENT  \nAGREEMENT  \nWHEREAS, Cargill, Incorporated ( \u201cCargill\u201d) and BioAmber S.A.S. ( \u201cBioamber \u201d) entered into a Development Agreement having an Effective \nDate of April 15 , 2010, as amended on July 5 , 2011 (the \u201cDevelopment Agreement \u201d);  \nWHEREAS, Cargill and Bioamber entered into a Commercial License Agreement having an Effective Date of April 15, 2010 (the  \u201cCommercial \nLicense\u201d);  \nWHEREAS, Bioamber now desires to amend the Development Agreement to allow Bioamber to fund a  research project being conducted by \nthe Biotechnology Research Institute ( \u201cBRI\u201d), which involves the molecular re -engineering of a Methylotroph owned by BRI and the development \nof a lab scale fermentation design for using the re -engineered  Methylotroph to make succinic acid or salts thereof from a methanol feedstock (the \n\u201cBRI Project \u201d). The BRI Project will be co -funded by funds available from the Canadian National Research Council;\n\n* Confidential  treatment requested CARGILL, INCORPORATED\nBy:\u00a0\u00a0 /s/ Pirkko Suominen\n\u00a0Name: Pirkko Suominen\nTitle: Director, Bio Technology Development \nCenter, Minneapol is\nDate:\u00a0 10/19/2011\nBIOAMBER, SAS\nBy:\u00a0\u00a0 /s/ Jean -Fran\u00e7ois\u00a0Huc\n\u00a0Name: Jean -Fran\u00e7ois\u00a0Huc\nTitle: President\nDate:\u00a0 October 15, 2011",
  "key_terms": "* Confidential treatment requested 1. Section 2.2 of the Development Agreement is hereby amended to allow Cargill at its sole discretion to apply [***] during the period of July 5, \n2011, through  September 30, 2011, to perform the Work Plan in addition to the [***] specified in the unamended Section 2.2. The terms for \ncompensation and expenses for these additional FTEs will be as provided for the original FTEs in Section 2.2.  \n2. Other than as expressly modified by this First Amendment, all terms and conditions of the Development Agreement continue without \nmodification. \nCARGILL, INCORPORATED  \nBio Technology Development Center  \u00a0 \u00a0BIOAMBER S.A.S.\n/s/ Jack Staboch \u00a0 \u00a0\u00a0/s/ Jim Millis\nSignature \u00a0 \u00a0Signature\nVP BioTDC \u00a0 \u00a0CTO\nTitle \u00a0 \u00a0Title\n7/14/11 \u00a0 \u00a07/18/11\n\nAMENDMENT 1 TO DEVELOPMENT AGREEMENT  \nThis is the First Amendment ( \u201cFirst Amendment \u201d) to the Development Agreement ( \u201cDevelopment Agreement \u201d) entered into on April 15,  2010, by \nand between Cargill, Incorporated through its Bio Technology Development Center, having its principal place of business at 15407 McGinty Road \nWest, Wayzata, Minnesota 55391 USA ( \u201cCargill\u201d) and BioAmber S.A.S., having a place of  business at Route de Bazancourt, F -51110, Pomacle \nFrance (\u201cBioAmber \u201d). This First Amendment will be effective as of July 5, 2011, upon the signature of both Cargill and BioAmber.  \nCargill and Bioamber mutually agree as follows:  \n\u00a0 \n\u00a0 \nThe Parties, through their authorized representatives, hereby agree to the terms and conditions of this First Amendment.  \n\u00a0 \n\u00a0 \nCargill  Confidential  \n* Confidential treatment requested 1. Section 2.2 of the Development Agreement is hereby amended to allow Cargill at its sole discretion to apply [***] during the period of July 5,\n\nAMENDMENTS TO COMMERCIAL LICENSE AGREEMENT AND DEVELOPMENT  \nAGREEMENT  \nWHEREAS, Cargill, Incorporated ( \u201cCargill\u201d) and BioAmber S.A.S. ( \u201cBioamber \u201d) entered into a Development Agreement having an Effective \nDate of April 15 , 2010, as amended on July 5 , 2011 (the \u201cDevelopment Agreement \u201d);  \nWHEREAS, Cargill and Bioamber entered into a Commercial License Agreement having an Effective Date of April 15, 2010 (the  \u201cCommercial \nLicense\u201d);  \nWHEREAS, Bioamber now desires to amend the Development Agreement to allow Bioamber to fund a  research project being conducted by \nthe Biotechnology Research Institute ( \u201cBRI\u201d), which involves the molecular re -engineering of a Methylotroph owned by BRI and the development \nof a lab scale fermentation design for using the re -engineered  Methylotroph to make succinic acid or salts thereof from a methanol feedstock (the \n\u201cBRI Project \u201d). The BRI Project will be co -funded by funds available from the Canadian National Research Council;\n\nWHEREAS, Cargill is  willing to allow Bioamber to fund the BRI Project and to conduct the Scale -up and Production Project, subject to the \nfollowing terms and conditions. Now therefore the Parties agree:  \nAmendment To the Development Agreement  \nA. Section 13.9 of the Development Agreement is amended to add the following at the end of the Section:  \n\u201cNotwithstanding the above, Bioamber may fund the BRI Project up until the Methylotroph (or re -engineered Methylotroph) demonstrates \nthe ability to produce succinic acid (or salts thereof) from any  feedstock at a concentration of [***] grams/liter succinic acid (or salts thereof). \nWithin thirty (30) days of the Methylotroph (or re -engineered Methylotroph) demonstrating such production levels of succinic acid, Bioamber will \ncease any  further funding and/or other support for the BRI Project. Further Bioamber will require that any unexpended funds received from \nBioamber be utilized for a project other than the BRI Project."
}